Aclaris Therapeutics Inc (NASDAQ: ACRS) established initial surge of 11.02% at $1.41, as the Stock market unbolted on Wednesday, before settling in for the price
On Friday, Aclaris Therapeutics Inc (NASDAQ: ACRS) was unchanged from the session before settling in for the closing price of $1.26. A 52-week range for
Aclaris Therapeutics Inc (NASDAQ: ACRS) open the trading on Wednesday, with a bit cautious approach as it glided -4.44% to $1.29, before settling in for
Aclaris Therapeutics Inc (NASDAQ: ACRS) On Tuesday, started off the session at the price of On Tuesday, remained unchanged from the previous trading day, before
On Tuesday, Aclaris Therapeutics Inc (NASDAQ: ACRS) was -2.65% drop from the session before settling in for the closing price of $1.13. A 52-week range
A new trading day began on Tuesday, with Aclaris Therapeutics Inc (NASDAQ: ACRS) stock price down -5.08% from the previous day of trading, before settling
Aclaris Therapeutics Inc (NASDAQ: ACRS) flaunted slowness of -10.74% at $1.08, as the Stock market unbolted on Thursday, before settling in for the price of
Aclaris Therapeutics Inc (NASDAQ: ACRS) kicked off on Monday, down -5.00% from the previous trading day, before settling in for the closing price of $1.40.
Aclaris Therapeutics Inc (NASDAQ: ACRS) kicked off on Monday, down -3.77% from the previous trading day, before settling in for the closing price of $1.59.
kicked off on Monday, with Aclaris Therapeutics Inc (NASDAQ: ACRS) stock price up 6.25% from the previous day of trading, before settling in for the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.